pluripotent embryonic stem cell-derived allogeneic neural stem cell therapy (University of California at Irvine)

N/A

Report date: 2025/01/26 16:46:01

Base Information

Drug Namepluripotent embryonic stem cell-derived allogeneic neural stem cell therapy (University of California at Irvine)

Drug Alias Namepluripotent stem cell-derived allogeneic neural stem cell therapy (UCI)pluripotent embryonic stem cell-derived allogeneic neural stem cell therapy (UCI)

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Neurogenic potential stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy

Mechanisms of ActionNeuroprotectants

TargetsUpdating

Therapy Area/IndicationsHuntington Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity of California Irvine

China Registration ClassN/A

Develop Information

Active CompaniesUniversity of California Irvine

Inactive CompaniesN/A

Active IndicationsHuntington Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A